Synonyms BRAF V600–mutant glioblastoma |
Introduction- |
Target |
Mechanism BRAF inhibitors |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. US |
First Approval Date27 Jun 2018 |
Target |
Mechanism MEK1 inhibitors [+1] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. US |
First Approval Date27 Jun 2018 |
Target |
Mechanism MEK1 inhibitors [+1] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. US |
First Approval Date29 May 2013 |
Start Date23 Jun 2022 |
Sponsor / Collaborator |
Start Date14 Jan 2022 |
Sponsor / Collaborator |
Start Date28 Dec 2021 |
Sponsor / Collaborator- |